Neylan John F. 4
4 · Angion Biomedica Corp. · Filed Dec 21, 2021
Insider Transaction Report
Form 4
Neylan John F.
See Remarks
Transactions
- Sale
Common Stock
2021-12-20$2.62/sh−358$938→ 35,136 total
Footnotes (1)
- [F1]The shares reported in this Form 4 were sold pursuant to a 10b5-1 trading plan adopted on March 18, 2021 by the reporting person solely to satisfy tax or other government withholding obligations in connection with the vesting of Restricted Stock Awards ("RSAs") granted by the Issuer.